8-K Announcements
6Material company update
May 19, 2026·SEC
Material company update
May 15, 2026·SEC
Material company update
Apr 23, 2026·SEC
Lifeward Ltd.(LFWD)Earnings, Financials & Key Ratios
LFWD•NASDAQ
$7.20
Price updated Jun 27, 2026
AboutLifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.Show more
- Revenue$22M-14.1%
- EBITDA-$17M-5.4%
- Net Income-$20M+31.2%
- EPS (Diluted)-17.16+57.1%
- Gross Margin38.25%+19.5%
- EBITDA Margin-75.15%-22.7%
- Operating Margin-76.66%-0.6%
- Net Margin-90.38%+19.9%
- ROE-146.12%-65.0%
LFWD Price & Volume
Lifeward Ltd. (LFWD) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operational Losses Threaten Lifeward Equity Solvency
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Contracting
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity and dilution
"Lifeward faces a precarious fundamental outlook characterized by a 22.1% year-over-year revenue contraction in 2026Q1 and a deeply entrenched pattern of value destruction. The company's inability to achieve operating leverage, evidenced by a $10.3M operating loss in the most recent quarter, suggests that the integration of the AlterG business has failed to stabilize the top line. Investors should remain cautious as the rapid depletion of equity to $6.3M and the reliance on debt financing, which reached $8.8M in 2026Q1, point toward an imminent risk of further shareholder dilution."
Verdict Logic
Negative: The company's accumulated deficit of -$295.5M and consistent negative free cash flow suggest an imminent liquidity crisis that likely necessitates dilutive capital raises.
LFWD Growth Metrics
Lifeward Ltd. (LFWD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years38.06%
3 Years58.72%
TTM-17.67%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM5.92%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM46.11%
Return on Capital
10 Years-89.19%
5 Years-49.64%
3 Years-67.4%
Last Year-108.54%
LFWD Recent Earnings
Lifeward Ltd. (LFWD) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 15, 2026Metric
Actual
Est
EPS
$6.70-467.8%
$1.18
Rev
$4M-32.1%
$6M
Q2 2026
Mar 18, 2026Metric
Actual
Est
EPS
$3.60-328.6%
$0.84
Rev
$5M-35.4%
$8M
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.20-122.2%
$0.09
Rev
$6M-21.3%
$8M
Q3 2025
Aug 14, 2025Metric
Actual
Est
EPS
$0.58-132.0%
$0.25
Rev
$6M-13.5%
$7M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $6.70vs $1.18-467.8% | $4Mvs $6M-32.1% |
| Q2 2026 | Mar 18, 2026 | $3.60vs $0.84-328.6% | $5Mvs $8M-35.4% |
| Q4 2025 | Nov 14, 2025 | $0.20vs $0.09-122.2% | $6Mvs $8M-21.3% |
| Q3 2025 | Aug 14, 2025 | $0.58vs $0.25-132.0% | $6Mvs $7M-13.5% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Lifeward Ltd. (LFWD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.20 | $11.6M | -0.42 | -14.14% | -90.38% | -146.12% | — | |
| $22.20 | $53.85M | -4.52 | -28.6% | -135.66% | -177.4% | — | |
| $0.05 | $1.72M | -0.01 | -23.44% | -38.16% | — | — | |
| $1.77 | $80.66M | -6.10 | — | -13535.24% | -21.84% | — | |
| $86.25 | $11.63B | 22.00 | 16.65% | 18.92% | 13.04% | — | |
| $15.43 | $1.76B | -12.65 | 8.28% | -25.66% | -50.82% | — |
Compare LFWD vs Peers
Lifeward Ltd. (LFWD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LFWD SEC Filings & Documents
Lifeward Ltd. (LFWD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when LFWD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LFWD Frequently Asked Questions
Lifeward Ltd. (LFWD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Lifeward Ltd.'s revenue?
Lifeward Ltd. (LFWD) reported $20.9M in revenue for fiscal year 2025. This represents a 257% increase from $5.9M in 2016.
How fast is Lifeward Ltd. growing?
Lifeward Ltd. (LFWD) saw revenue decline by 14.1% over the past year.
Is LFWD profitable?
Lifeward Ltd. (LFWD) reported a net loss of $25.9M for fiscal year 2025.
Dividend & Returns
What is LFWD's return on equity?
Lifeward Ltd. (LFWD) has a return on equity (ROE) of -146.1%. Negative ROE indicates the company is unprofitable.
What is Lifeward Ltd.'s free cash flow?
Lifeward Ltd. (LFWD) had negative free cash flow of $15.0M in fiscal year 2025, likely due to heavy capital investments.